Filing Details
- Accession Number:
- 0001209191-15-083226
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-03 16:39:02
- Reporting Period:
- 2015-12-01
- Filing Date:
- 2015-12-03
- Accepted Time:
- 2015-12-03 16:39:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1607965 | A. Andrew Hindman | 420 Saw Mill River Road Ardsley NY 10502 | Chief Business Dev. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-12-01 | 442 | $38.26 | 54,530 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sales pursuant to a 10b5-1 Plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
Billionaire Hedge Funds
